Science news

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

Fanapt® Treatment is Now Available to Adult Patients for the Acute Treatment of Manic or Mixed Episodes Associated with Bipolar I Disorder Approval Represents Significant...

Service and Working Animals Receive Free Eye Exams Across the U.S.

Registration Opens on April 1, 2024 MERIDIAN, Idaho, April 2, 2024 /PRNewswire/ -- The American College of Veterinary Ophthalmologists® (ACVO) is proud to announce registration...

ADAMA Launches New Cereal Fungicide Forapro® for Supercharged Disease Control and Higher Yields

BEIJING and TEL AVIV, Israel, April 2, 2024 /PRNewswire/ -- ADAMA Ltd. (SZSE: 000553), a leading crop protection company, has announced the European launch of...

Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY

HONG KONG and SHANGHAI, April 2, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or...

Unlocking Precision in Diagnosis: The Rise of Molecular Point-of-Care Solutions

DUBLIN, April 1, 2024 /PRNewswire/ -- The "Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition" report has been added to  ResearchAndMarkets.com's offering. Molecular point-of-care...

Delaware North launches expanded 'Bee the Difference' campaign with two craft cocktails for Earth Month

From April 1 to May 20, more than 100 Delaware North U.S. operating locations offering the 'Bee's Harvest Margarita' with PATRÓN Silver Tequila and...

Submission of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer's disease to the U.S. FDA completed

STOCKHOLM, April 1, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq: BIOA B) (Stockholm: BIOA B) partner Eisai announced today that Eisai has submitted a supplemental...

Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2023

TEL-AVIV, Israel, March 31, 2024 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator...

Latest articles